Benralizumab 17228-2730
Product NDC
17228-2730- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- December 15, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Benralizumab | 30 mg/mL |
Packaging Options(1)
1440 SYRINGE in 1 BOX (17228-2730-0) / 1 mL in 1 SYRINGE